2026 starts on an upbeat note – Quant Portfolios finish strong – Update 01/05/26

Note: This site now offers both a free and a paid subscription. Paid subscribers receive weekly Portfolio updates as soon as they’re released. Free subscribers still get full content, but Portfolio updates will be posted with at least a two-week delay. Want timely access to the new Adds/Removes? Click here.

What does Royal Bank of Canada do?

Royal Bank of Canada is a global financial heavyweight with businesses across personal and commercial banking, wealth management, insurance, and capital markets. It does everything from deposits and loans to investing, insurance, and institutional trading for individuals, companies, and governments worldwide. Founded in 1864, RBC is headquartered in Toronto.

Key Strengths

  • Record numbers: RY crushed fiscal ’25—net income up 25% to $20.4B, one of the strongest years in the bank’s history.
  • Capital muscle: CET1 at 13.5% gives them plenty of cushion and flexibility if the economy gets bumpy.
  • High-value momentum: Wealth Management and Capital Markets are firing, driving growth beyond plain-vanilla banking.
  • Shareholder-friendly: Dividend bumped 6% and management’s shooting for 17%+ ROE in FY ’26—confidence is loud and clear.
  • Market leader: Canada’s biggest bank, massive scale, global footprint, and a deep client base keep the moat wide.

Key Weaknesses

  • Pricey stock: Trading at a big premium—about 39% above peers—which caps upside with revenue growth only around 5%.
  • Credit pressure: Rising credit costs and mortgage renewals could weigh as past tailwinds start to fade.
  • Limited runway: With growth already priced in, the risk-reward looks tight at these levels.

Performance to 01-02-2026

Portfolio start date 6/27/25
Quant Alpha Weekly28.87%
EQAL (Russell 1000 Equal Weight ETF)9.19%
Portfolio start date 6/27/25
Quant 3019.65%
EQAL (Russell 1000 Equal Weight ETF)9.19%
Portfolio start date 4/14/23
Quant Alpha’s – Legacy265.44%
EQAL (Russell 1000 Equal Weight ETF)32.96%

The Quant Alpha Weekly Portfolio remains ahead of its benchmark. Up over 28% since it began on June 27, 2025.

The Quant 30 Portfolio managed to close ahead of the benchmark once again. It is up 19% since it began on June 27, 2025.

The Quant Alpha’s – Legacy Portfolio maintained its over 250% return since April 2023, in a classic Position Trading Portfolio implementation.

Fear & Greed Index: Source: CNN.COM

Do Small Cap stocks outperform in January?

The idea that stocks—especially small caps—tend to outperform in January due to tax-loss selling in December and reinvestment in the new year.

How accurate it actually is

  • Historically:
    • Real and measurable before the 1990s, strongest in small-cap stocks.
  • Modern era (last ~25 years):
    • Inconsistent and weak
    • January is positive about 60–65% of the time, only slightly better than a coin flip.
  • Returns:
    • Any excess return is usually small (often <1%)
    • Easily erased by volatility, taxes, or transaction costs.

Where it still shows up (sometimes)

  • Small-cap stocks more than large caps
  • After down years, when tax-loss selling is heavier
  • Mostly in the first 5–10 trading days, not the full month

Why it faded

  • Widely known → arbitraged away
  • Institutional and algorithmic trading dominate markets
  • Less retail tax-driven behavior
  • Global capital flows dilute calendar effects

Bottom line

  • The January Effect is not reliable enough to trade on its own
  • Today it’s more a curiosity than an edge
  • At best, it’s a minor tailwind, useful only when it aligns with:
    • Valuation
    • Liquidity
    • Trend
    • Broader economic cycle
Website Investment Educational Blog Posts –

All content on this site is for informational purposes only and does not constitute financial advice. Consult relevant financial professionals in your country of residence to get personalized advice before you make any trading or investing decisions. This post was written with the assistance of artificial intelligence. The original ideas and final review are human-generated. Disclaimer